Yahoo
OTC Markets OTCQX - Delayed Quote USD

Vireo Growth Inc. (VREOF)

12.55 +1.70 (+15.67%)
At close: September 4 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for VREOF
  • Previous Close 10.85
  • Open 11.00
  • Bid 12.30 x 20000
  • Ask 12.70 x 40300
  • Day's Range 11.00 - 12.55
  • 52 Week Range 8.91 - 22.50
  • Volume 52,254
  • Avg. Volume 31,428
  • Market Cap (intraday) 647.427M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -1.82
  • Earnings Date (est.) Nov 11, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 45.00

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

vireogrowth.com

520

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VREOF
30.28%
S&P/TSX Composite index (^GSPTSE)
14.58%

1-Year Return

VREOF
9.06%
S&P/TSX Composite index (^GSPTSE)
26.28%

3-Year Return

VREOF
139.05%
S&P/TSX Composite index (^GSPTSE)
77.72%

5-Year Return

VREOF
73.62%
S&P/TSX Composite index (^GSPTSE)
75.37%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 104.51M
Earnings -20.37M
Profit Margin -19.49%

Q2

FY25

Q3

FY25

Q4

FY25

0
50M
100M
-30.0%
-28.0%
-26.0%
-24.0%
-22.0%
-20.0%

Analyst Insights

View More

Analyst Price Targets

45.00
45.00 Average
12.55 Current
45.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.12%

  • Return on Assets (ttm)

    2.28%

  • Return on Equity (ttm)

    -18.88%

  • Revenue (ttm)

    511.67M

  • Net Income Avi to Common (ttm)

    -67.11M

  • Diluted EPS (ttm)

    -1.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.1M

  • Total Debt/Equity (mrq)

    109.79%

  • Levered Free Cash Flow (ttm)

    -42.95M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: